109 related articles for article (PubMed ID: 3912232)
1. Aspartic proteinases and their inhibitors.
Kay J
Biochem Soc Trans; 1985 Dec; 13(6):1027-9. PubMed ID: 3912232
[No Abstract] [Full Text] [Related]
2. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.
Rich DH
J Med Chem; 1985 Mar; 28(3):263-73. PubMed ID: 3882966
[No Abstract] [Full Text] [Related]
3. Development and testing of inhibitors of Candida aspartic proteinases.
Pichová I; Brozková K; Pavlícková L; Fusek M; Krízová I; Ruml T; Soucek M
Adv Exp Med Biol; 1998; 436():329-33. PubMed ID: 9561237
[No Abstract] [Full Text] [Related]
4. Pepstatin-insensitive carboxyl proteinases.
Oda K; Takahashi S; Shin T; Murao S
Adv Exp Med Biol; 1995; 362():529-42. PubMed ID: 8540367
[No Abstract] [Full Text] [Related]
5. The structure and function of the aspartic proteinases.
Davies DR
Annu Rev Biophys Biophys Chem; 1990; 19():189-215. PubMed ID: 2194475
[No Abstract] [Full Text] [Related]
6. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of aspartic proteinase inhibitors related to pepstatin.
Gunn JM; Owens RA; Liu WS; Glover GI
Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
[TBL] [Abstract][Full Text] [Related]
8. Pepstatin-insensitive carboxyl proteinases from prokaryotes. Catalytic residues and substrate specificities.
Oda K; Takahashi S; Ito M; Dunn BM
Adv Exp Med Biol; 1998; 436():349-53. PubMed ID: 9561241
[No Abstract] [Full Text] [Related]
9. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier S; Schmidt H; Turk V; von der Helm K
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6612-6. PubMed ID: 3045820
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhibitor binding in HIV-1 protease and in non-viral aspartic proteases: the role of the flap.
Gustchina A; Weber IT
FEBS Lett; 1990 Aug; 269(1):269-72. PubMed ID: 2201571
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.
James MN; Sielecki A; Salituro F; Rich DH; Hofmann T
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6137-41. PubMed ID: 6755464
[TBL] [Abstract][Full Text] [Related]
12. Aspartic proteinases in the digestive tract of marine decapod crustaceans.
Navarrete del Toro Mde L; García-Carreño F; López MD; Celis-Guerrero L; Saborowski R
J Exp Zool A Comp Exp Biol; 2006 Aug; 305(8):645-54. PubMed ID: 16788916
[TBL] [Abstract][Full Text] [Related]
13. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of a pepstatin-insensitive acid proteinase from Aspergillus niger var. Macrosporus.
Takahashi K; Tanokura M; Inoue H; Kojima M; Muto Y; Yamasaki M; Makabe O; Kimura T; Takizawa T; Hamaya T
Adv Exp Med Biol; 1991; 306():203-11. PubMed ID: 1812707
[No Abstract] [Full Text] [Related]
15. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
Omura S; Imamura N; Kawakita K; Mori Y; Yamazaki Y; Masuma R; Takahashi Y; Tanaka H; Huang LY; Woodruff HB
J Antibiot (Tokyo); 1986 Aug; 39(8):1079-85. PubMed ID: 3093433
[TBL] [Abstract][Full Text] [Related]
16. Extracellular aspartic proteinases from Candida yeasts.
Fusek M; Smith E; Foundling SI
Adv Exp Med Biol; 1995; 362():489-500. PubMed ID: 8540363
[No Abstract] [Full Text] [Related]
17. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A.
von der Helm K; Gürtler L; Eberle J; Deinhardt F
FEBS Lett; 1989 Apr; 247(2):349-52. PubMed ID: 2469601
[TBL] [Abstract][Full Text] [Related]
18. Identification of carboxyl residues in pepstatin-insensitive carboxyl proteinase from Pseudomonas sp. 101 that participate in catalysis and substrate binding.
Ito M; Narutaki S; Uchida K; Oda K
J Biochem; 1999 Jan; 125(1):210-6. PubMed ID: 9880819
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents.
Cooper JB; Foundling SI; Hemmings A; Watson FE; Sibanda BL; Blundell TL; Jones DM; Hallett A; Atrash B; Szelke M
Biochem Soc Trans; 1987 Aug; 15(4):751-4. PubMed ID: 3119394
[No Abstract] [Full Text] [Related]
20. Shewasin A, an active pepsin homolog from the bacterium Shewanella amazonensis.
Simões I; Faro R; Bur D; Kay J; Faro C
FEBS J; 2011 Sep; 278(17):3177-86. PubMed ID: 21749650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
